Subscribe to Newsletter
Business & Regulation Digital Technologies, Business Practice, Technology and Equipment

A Question of Security

Securing the bioeconomy is an ongoing challenge for companies across the life science and pharmaceutical sectors. Though companies from both sectors continue to innovate and adopt tools like AI to drive progress, the fact of the matter remains that pharma companies lag behind other businesses when it comes to the management of digital assets. This is also true of the industry’s adoption of pertinent cybersecurity systems. 

Last year, we spoke to Vishal Salvi, CISO at Infosys, and Charles Fracchia, founder BioBright and Vice-president of Data at Dotmatics,  about the issue. But how have things changed since then? The industry certainly hasn’t remained stagnant and as it grows and evolves, new vulnerabilities are sure to emerge.

He joined us for our inaugural Big Question – an anthology of articles exploring whether pharma can be remodeled using AI –  to share his thoughts on pharma’s relationship with cybersecurity and how the increased use of AI will impact it. 

Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine